These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34413003)

  • 41. Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.
    Rettig EM; Talbot CC; Sausen M; Jones S; Bishop JA; Wood LD; Tokheim C; Niknafs N; Karchin R; Fertig EJ; Wheelan SJ; Marchionni L; Considine M; Ling S; Fakhry C; Papadopoulos N; Kinzler KW; Vogelstein B; Ha PK; Agrawal N
    Cancer Prev Res (Phila); 2016 Apr; 9(4):265-74. PubMed ID: 26862087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status.
    Rooper LM; Lombardo KA; Oliai BR; Ha PK; Bishop JA
    Am J Surg Pathol; 2021 Apr; 45(4):488-497. PubMed ID: 33165092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.
    Thierauf J; Ramamurthy N; Jo VY; Robinson H; Frazier RP; Gonzalez J; Pacula M; Dominguez Meneses E; Nose V; Nardi V; Dias-Santagata D; Le LP; Lin DT; Faquin WC; Wirth LJ; Hess J; Iafrate AJ; Lennerz JK
    Oncologist; 2019 Oct; 24(10):1356-1367. PubMed ID: 30926674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
    Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
    Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting.
    Bedell M; Lewis DW; Seethala RR
    Head Neck Pathol; 2024 Jun; 18(1):51. PubMed ID: 38896376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.
    Afshari MK; Fehr A; Nevado PT; Andersson MK; Stenman G
    Genes Chromosomes Cancer; 2020 Nov; 59(11):652-660. PubMed ID: 32654217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.
    Magers MJ; Iczkowski KA; Montironi R; Grignon DJ; Zhang S; Williamson SR; Yang X; Wang M; Osunkoya AO; Lopez-Beltran A; Hes O; Eble JN; Cheng L
    Mod Pathol; 2019 Nov; 32(11):1666-1674. PubMed ID: 31189999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.
    Andersson MK; Åman P; Stenman G
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular methods for detection of prognostic and predictive markers in diagnosis of adenoid cystic carcinoma of the salivary gland origin.
    Šteiner P; Pavelka J; Vaneček T; Miesbauerová M; Skálová A
    Cesk Patol; 2018; 54(3):132-136. PubMed ID: 30445817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome-oriented clinicopathological reappraisal of sinonasal adenoid cystic carcinoma with broad morphological spectrum and high MYB::NFIB prevalence.
    Mauthe T; Meerwein CM; Holzmann D; Soyka MB; Mueller SA; Held U; Freiberger SN; Rupp NJ
    Sci Rep; 2024 Aug; 14(1):18655. PubMed ID: 39134604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metatypical Adenoid Cystic Carcinoma: A Variant Showing Prominent Squamous Differentiation With a Predilection for the Sinonasal Tract and Skull Base.
    Mathew EP; Todorovic E; Truong T; Dickson BC; Enepekides D; Poon I; Weinreb I
    Am J Surg Pathol; 2022 Jun; 46(6):816-822. PubMed ID: 34864773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genes.
    Chung HJ; Rajan S; Wu Z; Ferrone CK; Raffeld M; Lee I; Gagan J; Dampier C; Abdullaev Z; Tyagi M; Cimino PJ; Quezado M; Aldape K
    Acta Neuropathol; 2024 Oct; 148(1):54. PubMed ID: 39422766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.
    Tian Z; Li L; Zhang CY; Gu T; Li J
    J Oral Pathol Med; 2016 Oct; 45(9):698-703. PubMed ID: 26711587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.